JNJ

Johnson & Johnson · BX:JNJ

228.05 CHF1.34 +0.59%

Johnson & Johnson (BX:JNJ) last traded at 228.05 CHF, up 0.59% on the day. Over the past year the stock is up 52.78%. Its 52-week range is 150.25 to 229.99. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open228.54

Day range228.05 – 229.24

52-week range150.25 – 229.99

Volume32

Average volume (10 days)16

Market cap (USD)657.68 B

P/E41.38

EPS (TTM) (USD)6.59

Dividend yield1.93%

Beta (1 year)0.4905

Revenue (TTM) (USD)99.35 B

Employees140.80 K

Performance

+5.58%1 week

+1.60%1 month

+10.21%3 months

+26.66%6 months

+38.32%Year to date

+52.78%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Johnson & Johnson reports 94% success rate in trial of coronary artery deviceSeeking Alpha · 01 Nov 2026
Johnson & Johnson reports lower mortality rates with Impella heart pumpsSeeking Alpha · 01 Nov 2026
J&J Reports Positive Survival And Outcomes With Impella In HrpciReuters · 01 Nov 2026
Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study ResultsBusinessWire · 01 Nov 2026
Ayushman Bharat Digital Mission Can Transform Healthcare Through Data, Says NITI Aayog MemberBusinessworld · 01 Nov 2026
JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4?Zacks · 30 Oct 2026
Experts red-flag cancer drug price cuts as patented therapies see zero relief, markups exceed benchmarkMint · 29 Oct 2026
Over 100 of the 600-plus medicines listed by NPPA do not show a drop in pricesBusiness Line · 29 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.